196 related articles for article (PubMed ID: 31190827)
1. Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.
Rodríguez C; García T; Areces D; Fernández E; García-Noriega M; Domingo JC
Neuropsychiatr Dis Treat; 2019; 15():1193-1209. PubMed ID: 31190827
[No Abstract] [Full Text] [Related]
2. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M
Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216
[TBL] [Abstract][Full Text] [Related]
4. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
[TBL] [Abstract][Full Text] [Related]
5. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
Cornu C; Mercier C; Ginhoux T; Masson S; Mouchet J; Nony P; Kassai B; Laudy V; Berquin P; Franc N; Le Heuzey MF; Desombre H; Revol O
Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):377-384. PubMed ID: 28993963
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
Parletta N; Niyonsenga T; Duff J
PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
Rheims S; Herbillon V; Gaillard S; Mercier C; Villeuve N; Villéga F; Cances C; Castelnau P; Napuri S; de Saint-Martin A; Auvin S; Nguyen The Tich S; Berquin P; de Bellecize J; Milh M; Roy P; Arzimanoglou A; Bodennec J; Bezin L; Kassai B;
Epilepsia Open; 2024 Apr; 9(2):582-591. PubMed ID: 38173190
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
[No Abstract] [Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
Wu Q; Zhou T; Ma L; Yuan D; Peng Y
Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
[TBL] [Abstract][Full Text] [Related]
12. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
[TBL] [Abstract][Full Text] [Related]
13. Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children.
Carucci S; Romaniello R; Demuru G; Curatolo P; Grelloni C; Masi G; Liboni F; Mereu A; Contu P; Lamberti M; Gagliano A; Zuddas A
Eur Arch Psychiatry Clin Neurosci; 2022 Dec; 272(8):1453-1467. PubMed ID: 35672606
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of omega-3 supplementation in reducing ADHD associated symptoms in children as measured by the Conners' rating scales: A systematic review of randomized controlled trials.
Abdullah M; Jowett B; Whittaker PJ; Patterson L
J Psychiatr Res; 2019 Mar; 110():64-73. PubMed ID: 30594823
[TBL] [Abstract][Full Text] [Related]
16. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.
Matsudaira T; Gow RV; Kelly J; Murphy C; Potts L; Sumich A; Ghebremeskel K; Crawford MA; Taylor E
J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):775-82. PubMed ID: 26682998
[TBL] [Abstract][Full Text] [Related]
18. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
19. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children with Attention Deficit and Hyperactivity Disorder.
Fuentes-Albero M; Martínez-Martínez MI; Cauli O
Brain Sci; 2019 May; 9(5):. PubMed ID: 31126106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
